TerminatedPhase 3

Erector Spinae Plane Block With Bupivacaine for Medical Thoracoscopy

Stopped: interim, lack of obvious benefit

United States33 participantsStarted 2024-03-28

Plain-language summary

PlAcebo versus erector spINae pLane block for mEdical ThoracoScopy Study (PAINLESS). This is a prospective triple-blind, randomized controlled trial that evaluates the efficacy of erector spinae plane block (ESPB) with Bupivacaine in reducing pain after medical thoracoscopy (MT) in addition to monitored anesthesia care vs monitored anesthesia care alone.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Referral for medical thoracoscopy * Age ≥ 18 Exclusion criteria: * Inability to provide informed consent. * Study subject has any disease or condition that interferes with safe completion of the study including: * Allergic reaction to Bupivacaine. * Need for pleurodesis. * Allergies to lidocaine or other local anesthetics. * Pregnancy. * Advanced liver disease where the clinician deems the procedure unsafe.

What they're measuring

Visual Analog Scale (VAS) for Pain

Timeframe: 2 hours after the intervention

Trial details

NCT IDNCT06313632

SponsorIcahn School of Medicine at Mount Sinai

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-19

View on ClinicalTrials.gov More Pleural Disease trials